The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease
Open accessAbstract
The blood–brain barrier (BBB) limits the entry of neurotoxic blood-derived products and cells into the brain that is required for normal neuronal functioning and information processing. Pericytes maintain the integrity of the BBB and degenerate in Alzheimer’s disease (AD). The BBB is damaged in AD, particularly in individuals carrying apolipoprotein E4 ( APOE4) gene, which is a major genetic risk factor for late-onset AD. The mechanisms underlying the BBB breakdown in AD remain, however, elusive. Here, we show accelerated pericyte degeneration in AD APOE4 carriers >AD APOE3 carriers >non-AD controls, which correlates with the magnitude of BBB breakdown to immunoglobulin G and fibrin. We also show accumulation of the proinflammatory cytokine cyclophilin A (CypA) and matrix metalloproteinase-9 (MMP-9) in pericytes and endothelial cells in AD ( APOE4 > APOE3), previously shown to lead to BBB breakdown in transgenic APOE4 mice. The levels of the apoE lipoprotein receptor, low-density lipoprotein receptor-related protein-1 (LRP1), were similarly reduced in AD APOE4 and APOE3 carriers. Our data suggest that APOE4 leads to accelerated pericyte loss and enhanced activation of LRP1-dependent CypA–MMP-9 BBB-degrading pathway in pericytes and endothelial cells, which can mediate a greater BBB damage in AD APOE4 compared with AD APOE3 carriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The loss of pericytes is probably caused by increased expression of friend leukemia virus integration 1 (Fli-1) after being activated.503”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [503]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Human APOE4 carriers compared with non-carriers develop accelerated BBB breakdown and pericyte degeneration (229, 230, 267, 516, 691, 702), early neurovascular dysfunction (494, 531, 584), impaired cerebrovascular reactivity (227, 568), and diminished regional BBB uptake of glucose (457, 486).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These blood-derived proteins are often found colocalized with A 𝛃 (267, 509, 527) and are more pronounced in APOE4 carriers compared with noncarriers (230, 267, 516, 691).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Post mortem studies show vascular capillary leakages of blood-derived proteins in the prefrontal and entorhinal cortex and hippocampus of AD patients including perivascular accumulation of fibrin(ogen), thrombin, albumin, immunoglobulin G (IgG), and iron-containing proteins such as hemosiderin (120, 125, 230, 267, 412, 509, 527, 691).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further evidence of BBB breakdown in AD is repeatedly observed in numerous post mortem human studies showing reduced capillary length and microvascular degeneration with diminished TJ protein expression, capillary basement membrane alterations, and brain endothelial degeneration (36, 40, 230, 516, 527, 656).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Brain pericytes and endothelial cells in AD APOE4 carriers exhibit increased activity of BBB-degrading CypA-MMP-9 pathway compared with noncarriers (230).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Activation of CypAMMP-9 pathway associated with BBB breakdown has also been shown in human APOE4 carriers compared with noncarriers, as indicated by CSF (229) and post mortem BBB tissue (230) analyses.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In AD patients, BBB damage is associated with loss of pericytes,503 while the decrease in pericytes is followed by an increase in activated microglia.504”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [503]
The cited source says what the claim attributes to it.
In the citing paper
“For example, APOE4 carriers at risk for sporadic AD compared with non-carriers develop BBB breakdown (229, 230, 267, 516, 691, 702) and early cerebrovascular dysfunction (227, 457, 486, 494, 531, 568, 584)”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
The cited source says what the claim attributes to it.
In the citing paper
“Activation of CypA-MMP-9 pathway associated with BBB breakdown has been also shown in human APOE4 carriers by cerebrospinal fluid (CSF) analysis (229) and post mortem brain tissue analysis (230, 267).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, PDGFR 𝛃 immunostaining revealed significantly reduced pericyte coverage of brain capillaries as well as reduced pericyte numbers in AD cortex and hippocampus compared with control brains (527), which is accelerated by APOE4 gene (230).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
The cited source says what the claim attributes to it.
In the citing paper
“AD brain microvessels also exhibit reduced levels of LRP1, a major A 𝛃 clearance receptor at the BBB (137, 152, 230, 410, 535).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
Self-citationRetractedThe Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Self-citationThe role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Self-citationShibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Self-citationApolipoprotein E controls cerebrovascular integrity via cyclophilin A
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293 · cited 11×
“Microvascular capillary length was quantified as the length of lectin-positive endothelial profiles (<6 mm in diameter) determined using the ImageJ plug-in length analysis tool from 15 images per specimen derived from five randomly selected fields in the cortex (420mm 420 mm) per section from three non-adjacent ( 100…”
BackgroundMethodResultInfluentialSelf-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 657
Altered hemodynamics and vascular reactivity in a mouse model with severe pericyte deficiency
Stobart, J. L., Erlebach, E., Glück, C., Huang, S., Barrett, M. J. P., Li, M., Vinogradov, S. A., Klohs, J., Zarb, Y., Keller, A., et al. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221147366 · Cited by 14
Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases
Abyadeh, M., Gupta, V., Paulo, J. A., Sheriff, S., Shadfar, S., Fitzhenry, M. J., Amirkhani, A., Gupta, V. B., Salekdeh, G. H., Haynes, P. A., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0312-1 · Cited by 15
Wu, W., Huang, J., Han, P., Zhang, J., Wang, Y., Jin, F., & Zhou, Y. (2023) · Molecules · doi:10.3390/molecules28227631 · Cited by 15
Ricci, F., Martorana, A., Bonomi, C. G., Serafini, C., Mercuri, N. B., Koch, G., & Motta, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230792 · Cited by 14
Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
Fang, X., Fan, F., & Roman, R. J. (2024) · Journal of Experimental Neurology · doi:10.33696/neurol.5.087 · Cited by 17
Possible effects of Porphyromonas gingivalis on the blood–brain barrier in Alzheimer’s disease
Olsen, I. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1925540 · Cited by 15
Rasile, M., Lauranzano, E., Mirabella, F., & Matteoli, M. (2021) · FEBS Journal · doi:10.1111/febs.16020 · Cited by 14
Peoples, N., & Strang, C. J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.620090 · Cited by 14
Плотников, М. Б., Анищенко, А. М., Khlebnikov, А. I., & Schepetkin, I. A. (2025) · Molecules · doi:10.3390/molecules30112353 · Cited by 13
Stamenković, S., Li, Y., Waters, J., & Shih, A. Y. (2023) · Stroke · doi:10.1161/strokeaha.122.037156 · Cited by 14
Matsuo, K., & Nishihara, H. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390978 · Cited by 14
Gastfriend, B. D., Snyder, M. E., Holt, H., Daneman, R., Palecek, S. P., & Shusta, E. V. (2024) · Science Advances · doi:10.1126/sciadv.adi1737 · Cited by 16
Vascular Function and Ion Channels in Alzheimer's Disease
Taylor, J. L., Baudel, M. A. S. M., Nieves‐Cintrón, M., & Navedo, M. F. (2024) · Microcirculation · doi:10.1111/micc.12881 · Cited by 13
Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes
El‐Ghazawi, K., Eyo, U. B., & Peirce, S. M. (2024) · Microcirculation · doi:10.1111/micc.12877 · Cited by 14
Wellman, S. M., Forrest, A. M., Douglas, M. M., Subbaraman, A., Zhang, G., & Kozai, T. D. Y. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122963 · Cited by 12
Harding, A., Kanagasingam, S., Welbury, R. R., & Singhrao, S. K. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-96881-6_13 · Cited by 14
Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy
Orchard, P. J., Markowski, T. W., Higgins, L., Raymond, G. V., Nascene, D. R., Miller, W. P., Pierpont, E. I., & Lund, T. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-44140-3 · Cited by 13
Zaldua, S., Damen, F. C., Pisharody, R., Thomas, R., Fan, K. D., Ekkurthi, G. K., Scheinman, S. B., Alahmadi, S., Marottoli, F. M., Alford, S. T., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03919 · Cited by 13
Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk
Amontree, M., Deasy, S., Turner, R. S., & Conant, K. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1188065 · Cited by 13
Lv, M., Ma, X., Zhang, K., Zhang, M., Ji, Y., Cheng, L., Shao, X., Guan, Z., Cui, J., Gao, Y., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110743 · Cited by 12
Raghav, D., Shukla, S., & Jadiya, P. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167169 · Cited by 12
Evidence of Pericyte Damage in a Cognitively Normal Cohort
Haghdel, A., Smith, N. M., Glodzik, L., Li, Y., Wang, X. H., Crowder, T., Zhu, Y., Butler, T., Blennow, K., McIntire, L. B., et al. (2024) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000623 · Cited by 12
Modeling the Blood–Brain Barrier to Understand Drug Delivery in Alzheimer’s Disease
Wasielewska, J. M., Chaves, J., White, A. R., & Oikari, L. E. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch7 · Cited by 13
Human brain organoids in Alzheimer’s disease
Kang, Y. J., & Cho, H. (2021) · Organoid · doi:10.51335/organoid.2021.1.e5 · Cited by 13
Carnevale, L., Perrotta, M., Mastroiacovo, F., Perrotta, S., Migliaccio, A., Fardella, V., Pacella, J., Fardella, S., Pallante, F., Carnevale, R., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21940 · Cited by 12
Blood–Brain Barrier Transport of Alzheimer’s Amyloid β-Peptide
Nelson, A. R., Sagare, A. P., & Zloković, B. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00009-5 · Cited by 12
Geranmayeh, M. H., Nourazarian, A., Avcı, Ç. B., Rahbarghazi, R., & Farhoudi, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0286-4 · Cited by 12
Papotti (2024) · doi:10.1177/13872877241284213 · Cited by 11
Multisite chronic pain: association with cognitive decline and post-mortem Alzheimer’s biomarkers
Bell, T. R., Franz, C. E., Lerman, I. R., Williams, M. E., Fennema‐Notestine, C., Panizzon, M. S., Elman, J. A., Bennett, D. A., & Kremen, W. S. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf208 · Cited by 12
Accelerated midlife endocrine and bioenergetic brain aging in APOE4 females
Wang, T., Mao, Z., Shang, Y., Merlini, S., Vitali, F., Wiegand, J. L., & Brinton, R. D. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632877 · Cited by 12
Greco, G. A., Rock, M. B., Amontree, M., Lanfranco, M. F., Korthas, H. T., Hong, S. H., Turner, R. S., Rebeck, G. W., & Conant, K. E. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106057 · Cited by 11
Older adults with reduced cerebrovascular reactivity exhibit high white matter hyperintensity burden
Kapoor, A., Dutt, S., Alitin, J. P. M., Sible, I. J., Marshall, A. J., Shenasa, F., Engstrom, A. C., Gaubert, A., Shao, X., Bradford, D. R., et al. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.03.006 · Cited by 11
Xie, J., Lan, Y., Zou, C., He, J., Huang, Q., Zeng, J., Pan, M., Mei, Y., Luo, J., & Zou, D. (2024) · BMC Genomics · doi:10.1186/s12864-024-10447-3 · Cited by 12
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting
Sandoval, K. E., & WITT, K. A. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001117 · Cited by 14
Unraveling the Role of LRP1 in Alzheimer’s Disease: A Focus on Aβ Clearance and the Liver-Brain Axis
Yang, W., Wei, Z., & Wang, T. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02339-2 · Cited by 14
Liu, Y., Dong, J., Song, Q., Zhang, N., Wang, W., Gao, B., Tian, S., Dong, C., Liang, Z., Xie, L., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.570848 · Cited by 12
Aβ inhibits mesenchymal stem cell–pericyte transition through MAPK pathway
Xu, L., Li, J., Luo, Z., Wu, Q., Fan, W., Yao, X., Li, Q., Yan, H., & Wang, J. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy072 · Cited by 11
Li, D., Hagen, C. E., Fett, A. R., Bui, H. H., Knopman, D. S., Vemuri, P., Machulda, M. M., Jack, C. R., Petersen, R. C., & Mielke, M. M. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.005 · Cited by 12
Taccola, C., Barnéoud, P., Cartot‐Cotton, S., Valente, D., Schussler, N., Saubaméa, B., Chasseigneaux, S., Cochois, V., Mignon, V., Curis, E., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108588 · Cited by 12
A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer’s Disease
Arora, S., Sharma, D., Layek, B., & Singh, J. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00611 · Cited by 11
Schirò, G., & Balistreri, C. R. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106951 · Cited by 11
LRP1 at the crossroads of Aβ clearance and therapeutic targeting in Alzheimer’s disease
Deng, Y., Yin, H., Lu, Z., Lan, H., Liu, W., Zuo, C., Pan, N., Tian, X., & Gong, Q. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1669405 · Cited by 13
Counil, H., Silva, R. O., Rabanel, J., Zaouter, C., Haddad, M., Khedher, M. R. B., Brambilla, D., Fülöp, T., Patten, S. A., & Ramassamy, C. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70027 · Cited by 12
Enlarged perivascular spaces are associated with decreased brain tau deposition
Kang, K. M., Byun, M. S., Yi, D., Lee, K. H., Kim, M. J., Ahn, H., Jung, G., Lee, J., Kim, Y. K., Lee, Y., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14040 · Cited by 9
Sharpening the tools for pericyte research
Berthiaume, A., & Shih, A. Y. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0437-9 · Cited by 10
The Application of Ultrasound‐Induced Blood–Brain Barrier Opening in Neurology and Immunology
Jiang, A., Wang, Z., Song, D., Zhang, X., Guan, M., Li, X., Tan, J., He, Y., Han, W., Ding, X., et al. (2025) · Small · doi:10.1002/smll.202502699 · Cited by 9
Thedim, M., Hu, J., Maher, M., Wiener-Kronish, J. P., Saxena, R., & Vacas, S. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.05.014 · Cited by 9
Mi, X., Ye, Z.-L., Zhang, X., Chen, X., & Dai, X. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00751-2 · Cited by 12
Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders
Bicker, J., Alves, G., Fonseca, C., Falcão, A. C., & Fortuna, A. C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105226 · Cited by 11
Multiscale imaging informs translational mouse modeling of neurological disease
Wang, Y., LeDue, J. M., & Murphy, T. H. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.006 · Cited by 13
Boutros, S. W., Zimmerman, B., Nagy, S. C., Unni, V. K., & Raber, J. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01966-8 · Cited by 9
Effects of repeated sleep deprivation on brain pericytes in mice
Wu, Y., Li, P., Bhat, N. R., Fan, H., & Liu, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-40138-0 · Cited by 11
Apolipoprotein E Drives Early Blood–Brain Barrier Damage in Alzheimer’s Disease
Zhang, Q., & Xie, C. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00596-2 · Cited by 9
Quattrini, G., Marizzoni, M., Pizzini, F. B., Galazzo, I. B., Aiello, M., Didic, M., Soricelli, A., Albani, D., Romano, M., Blin, O., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210531 · Cited by 10
Initiative, A. D. N., Wang, J., Peng, G., Liu, P., Tan, X., & Luo, B. (2019) · Cognitive Neurodynamics · doi:10.1007/s11571-019-09536-x · Cited by 10
Berthiaume, A., Schmid, F., Stamenković, S., Coelho‐Santos, V., Nielson, C. D., Weber, B., Majesky, M. W., & Shih, A. Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.28.489881 · Cited by 9
Haferkamp, U., Hartmann, C., Abid, C. L., Brachner, A., Höchner, A., Gerhartl, A., Harwardt, B., Leckzik, S., Leu, J., Metzger, M., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00471-y · Cited by 12
Biofluid biomarkers for Alzheimer’s disease
Wang, S., Xie, S., Zheng, Q., Zhang, Z., Wang, T., & Zhang, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1380237 · Cited by 9
Kadam, R., Gupta, M., Lazarov, O., & Prabhakar, B. S. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae134 · Cited by 8
Wu, Y., Lehtonen, Š., Trontti, K., Kauppinen, R., Kettunen, P., Leinonen, V., Laakso, M., Kuusisto, J., Hiltunen, M., Hovatta, I., et al. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00576-y · Cited by 7
Dik, D., Halliday, G. M., Sytnyk, V., & Shepherd, C. E. (2025) · Brain · doi:10.1093/brain/awaf305 · Cited by 9
Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026) · Cell · doi:10.1016/j.cell.2026.06.006 · Cited by 12
Alvariño, R., Alfonso, A., Pech-Puch, D., Gegunde, S., Rodrı́guez, J., Vieytes, M. R., Jiménez, C., & Botana, L. M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00208 · Cited by 11
Håglin, S., Koch, E. M., Hackenhaar, F. S., Nyberg, L. H., & Kauppi, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-35316-z · Cited by 8
Endothelial Cell APOE3 Regulates Neurovascular, Neuronal, and Behavioral Function
Marottoli, F. M., Zhang, H., Flores-Barrera, E., de la Villarmois, E. A., Damen, F. C., Fernández, A. M. M. M., Blesson, H. V., Chaudhary, R., Nguyen, A. L., Nwokeji, A. E., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319816 · Cited by 7
McCaulley, M. E., & Grush, K. A. (2017) · International Journal of Alzheimer s Disease · doi:10.1155/2017/2438901 · Cited by 8
Pang, J., Wu, Y., Peng, J., Yang, P., Chen, L., & Jiang, Y. Q. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.726520 · Cited by 8
Li, W., Zou, J., Shang, J., Gao, C., Sun, R., Liu, R., Cao, H., Wang, Y., & Zhang, J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.850857 · Cited by 11
Bonnar, O., Shaw, K., Anderle, S., Grijseels, D. M., Clarke, D., Bell, L., King, S. L., & Hall, C. N. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231172842 · Cited by 8
The impact of pericytes on the brain and approaches for their morphological analysis
Kolinko, Y., Králíčková, M., & Tonar, Z. (2018) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2018.04.003 · Cited by 8
Johnson, L. A. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313627 · Cited by 8
Neuropathological links between T2DM and LOAD: systematic review and meta-analysis
Lemche, E., Hortobágyi, T., Kiecker, C. M., & Turkheimer, F. (2025) · Physiological Reviews · doi:10.1152/physrev.00040.2024 · Cited by 9
Xin, X., Zhang, H., Yang, C., Wang, X., Zhang, L., Ma, J., & Wang, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1650254 · Cited by 7
Pericyte derivation and transplantation for blood-CNS barrier reconstitution in CNS disorders
Kim, H., Wu, K. L., Tam, K.-W., Chan, Y., & Shum, D. K. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.12.007 · Cited by 7
P2Y1 receptor in Alzheimer’s disease
Luo, S., Wang, Y., & Hisatsune, T. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-02103 · Cited by 8
Osborne, O., Daftari, M., Naranjo, O., Johar, A. N., Brooks, S., Colbert, B., Torices, S., Lewis, E., Sendaydiego, J., Drexler, G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114848 · Cited by 8
Exploring non-canonical targets in Alzheimer’s disease: a departure from the norm
Jain, S., & Chauhan, N. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00908-7 · Cited by 7
Can Astrocytes Be a Target for Precision Medicine?
Allen, C. F., Shaw, P. J., & Ferraiuolo, L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_7 · Cited by 7
New APOE-related therapeutic options for Alzheimer’s disease
Li, Z. (2019) · AIP conference proceedings · doi:10.1063/1.5085515 · Cited by 8
Anderson, E. L., Williams, D. M., Walker, V. M., & Davies, N. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-05225-8 · Cited by 8
Disrupted vasculature and blood–brain barrier in H untington disease
Waldvogel, H. J., Dragunow, M., & Faull, R. L. M. (2015) · Annals of Neurology · doi:10.1002/ana.24445 · Cited by 7
Humberg, A., Dzietko, M., Schulz, S., Felderhoff-Müser, U., Hüning, B. M., Stein, A., Fortmann, M. I., Marissen, J., Rausch, T. K., Herting, E., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.033432 · Cited by 7
Li, S., Song, H., Sun, Y., Sun, Y., Zhang, H., & Gao, Z. (2024) · Biochimie · doi:10.1016/j.biochi.2024.03.015 · Cited by 6
Advances in Research on Meningeal Lymphatic Vessels in Central Nervous System Diseases
Shen, H., Zhu, B., Qian, Y., Jin, J., Zhou, J., Peng, G., & Mo, J. (2024) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000010872 · Cited by 7
Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease
Li, X., Li, Z., Chen, H., Guo, H., Ge, Y., Dong, F., Zhang, F., & Zhang, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115199 · Cited by 7
APOE4 modulates the association between DTI‐ALPS index and Alzheimer's pathologies
Ks, K., Park, C., Byun, M. S., Yi, D., Nam, H., Ryu, J., Jung, J. H., Jung, G., Ahn, H., Lee, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70837 · Cited by 6
Neurovascular dysfunction in the development and progression of neuroinflammatory diseases
Gowdy, J., Ahn, J. J., Miller, R. H., & Islam, Y. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1741928 · Cited by 7
Joshi, A., Giorgi, F. M., & Sanna, P. P. (2024) · eNeuro · doi:10.1523/eneuro.0118-24.2024 · Cited by 6
Etuzé, T., Triniac, H., Zheng, Z., Vivien, D., & Dubois, F. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106896 · Cited by 8
History of hypertensive disorders of pregnancy and risk of Alzheimer’s disease and vascular dementia
Kaur, S., Darden, C. J., Adegbola, G. M., & Warrington, J. P. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101198 · Cited by 6
Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution
Patel, D. D., Marsic, D., Periasamy, R., Zolotukhin, S., & Lipinski, D. M. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.8.28 · Cited by 6
Regulation of Cerebral Blood Flow: Response to Cytochrome P450 Lipid Metabolites
Harder, D. R., Rarick, K. R., Gebremedhin, D., & Cohen, S. S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170025 · Cited by 7
Single-cell multi-region dissection of brain vasculature in Alzheimer’s DiseasePreprint
Sun, N., Akay, L. A., Murdock, M. H., Park, Y., Bubnys, A., Galani, K., Mathys, H., Jiang, X., Ng, A. P., Bennett, D. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.09.479797 · Cited by 6
Bowirrat, A., Pinhasov, A., Bowirrat, A., & Badgaiyan, R. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178253 · Cited by 6
Zhang, X., Liu, Z., Li, Y., He, J., Yang, L., Yan, Y., Tong, S., Wang, Y., & Zhang, T. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119250 · Cited by 5
Pediaditakis, I., Tsakali, S., Lemieux, M. R., Brennan, M., Robinson, W. H., Papapetropoulos, S., & Papapetropoulos, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100118 · Cited by 8
Unraveling Alzheimer’s: Exploring the Gut Microbiota–Brain Axis as a New Frontier in Understanding
Rashid, S. M., Razak, R., Tantray, A. K., James, A. W., Showkat, N., Shehjar, F., Jan, F., Ahmad, S. B., Khan, A., & Shah, Z. A. (2024) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad1010003 · Cited by 5
Screening and Identification of Brain Pericyte‐Selective Markers
Kang, M., Nasrolahi, A., Cheng, F., & Yao, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70247 · Cited by 5
Chappus-McCendie, H., Poulin, M.-A., Chouinard‐Watkins, R., Vandal, M., Calon, F., Lauzon, M.-A., & Plourde, M. (2022) · Aging Brain · doi:10.1016/j.nbas.2022.100046 · Cited by 5
Berk-Rauch, H., Choudhury, A., Richards, A. T., Singh, P. K., Chen, Z., Norris, E. H., Strickland, S., & Ahn, H. J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1064178 · Cited by 5
Metadata
- Authors
- Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V.
- Affiliations
- University of Southern California (US)
- University of California, San Francisco (US)
- Department of Physiology and Biophysics, Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2015-03-11
- Volume
- 36
- Issue
- 1
- Pages
- 216-227
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC4758554
- OpenAlex
- W2055467683
- Cited by
- 649
- References
- 41
- Citations by year
- 2026: 54 · 2025: 62 · 2024: 72 · 2023: 63 · 2022: 69 · 2021: 85 · 2020: 71 · 2019: 49 · 2018: 41 · 2017: 35 · 2016: 29 · 2015: 18
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Scholars Repository - LLU (Loma Linda University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG023084, R01AG039452, R37AG023084, P50-AG05142, P50AG005142, R37AG23084, RF1AG039452)
- National Institute of Neurological Disorders and Stroke (R37NS034467, R01NS034467, R37NS34467)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, APOE ε4, blood-brain barrier disruption, pericyte degeneration, cyclophilin A, MMP-9, LRP1, IgG, fibrin, inflammatory cytokines, endothelial cells, APOE ε4 carriers
- MeSH terms
- Aged, Aged, 80 and over, Alleles, Alzheimer Disease, Blood-Brain Barrier, Cell Count, Endothelium, Vascular, Female, Humans, Male, Cohort Studies, Protein Isoforms, Pericytes, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
